Fifth Third Bancorp’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
JGCM
Fifth Third Bancorp's PJP Position: Q2 2026 in Review
Fifth Third Bancorp increased its Invesco Pharmaceuticals ETF (PJP) stake by 12% in Q2 2026, buying an estimated $4.54K and bringing the position to 389 shares worth $46.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3256.
Fifth Third Bancorp first reported a position in PJP in Q2 2013 and has held it in 27 quarters since. The position peaked at $105K in Q4 2015. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.
- Fifth Third Bancorp held 389 shares of Invesco Pharmaceuticals ETF worth $46.1K as of Q2 2026.
- Fifth Third Bancorp bought 42 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $4.54K.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3256 holding.
- Fifth Third Bancorp first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 27 quarters since.
- Fifth Third Bancorp's Invesco Pharmaceuticals ETF position peaked at $105K in Q4 2015.
- 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.
Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.